Investigation of Efficacy of Use of a Bandage

December 7, 2022 updated by: University of Aarhus

Investigation of Efficacy of Use of a Bandage to Prevent Hip Dislocation After Total Hip Arthroplasty in Patients With Previous Dislocation

This trial investigates the effectiveness of using a bandage after dislocation of the hip after total hip arthroplasty.

Patients with a dislocated hip after total hip arthroplasty coming to the emergency department to have the hip relocated will be asked to participate in the trial. The patients will be randomised to either a bandage that reduces flexion, adduction and internal rotation of the hip or no bandage.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This trial investigates the effectiveness of using a bandage after dislocation of the hip after total hip arthroplasty.

Patients with a dislocated hip after total hip arthroplasty coming to the emergency department to have the hip relocated will be asked to participate in the trial. The patients will be randomised to either a bandage that reduces flexion, adduction and internal rotation of the hip or no bandage. Patients in the intervention group will use the bandage for 12 weeks and patients in the control group will receive the normal treatment which is information by a physiotherapist on movement restrictions.

50 patients will be allocated in the intervention group and 50 patients will be allocated to the control group.

We will investigate:

  1. Whether there is a difference in number of dislocations between the two groups in the project period (12 weeks).
  2. Patients' hip function, quality of life and satisfaction with the treatment in the two groups
  3. The safety, wear and durability of the bandage after 12 weeks of use

Study Type

Interventional

Enrollment (Actual)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Holstebro, Denmark, 7500
        • Holstebro Regional Hospital
      • Viborg, Denmark, 8800
        • Viborg Regional Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Has had at least one previous hip dislocation after total hip arthroplasty

Exclusion Criteria:

  • Dislocation in other directions than posterior/superior
  • Loose prosthesis
  • wounds in the area of skin that is in contact with the bandage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
HipStop bandage for 12 weeks to prevent dislocation of the hip
12 weeks use of a bandage to prevent hip dislocations in patients with previous dislocations
No Intervention: control
normal procedure after dislocation of hip which is information on movement restrictions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
number of dislocations
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hip function
Time Frame: 12 weeks
Oxford Hip Score, scores running from 0 to 48 with 48 being the best outcome
12 weeks
Helat-related quality of life
Time Frame: 12 weeks
SF-36, a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability
12 weeks
Patient satisfaction
Time Frame: 12 weeks
questions to patients
12 weeks
Safety, wear and durability of bandage
Time Frame: 12 weeks
Questionnaire to physiotherapists
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maiken Stilling, PhD, University of Aarhus

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2015

Primary Completion (Actual)

December 1, 2021

Study Completion (Actual)

August 31, 2022

Study Registration Dates

First Submitted

November 19, 2015

First Submitted That Met QC Criteria

August 12, 2021

First Posted (Actual)

August 19, 2021

Study Record Updates

Last Update Posted (Estimate)

December 8, 2022

Last Update Submitted That Met QC Criteria

December 7, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HipStop

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Dislocation

Clinical Trials on Hipstop bandage

Subscribe